Marlene Troch
Overview
Explore the profile of Marlene Troch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
266
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mair M, Maj-Hes A, Nussbaumer-Proll A, Puhr R, Christenheit A, Troch M, et al.
Infect Agent Cancer
. 2023 Feb;
18(1):9.
PMID: 36782325
Background: Patients with cancer are at high risk for severe courses of COVID-19. Based on (pre-)clinical data suggesting a potential protective effect due to the immunomodulating properties of azithromycin, we...
2.
Kiesewetter B, Troch M, Mayerhoefer M, Dolak W, Simonitsch-Klupp I, Raderer M
Oncologist
. 2015 Dec;
21(1):72-5.
PMID: 26621040
Background: The immunomodulatory drugs (IMiDs) thalidomide and lenalidomide have both been tested for treatment of mucosa-associated lymphoid tissue (MALT) lymphoma, with lenalidomide, in particular, showing promising activity. However, long-term results...
3.
Dolak W, Kiesewetter B, Mullauer L, Mayerhoefer M, Troch M, Trauner M, et al.
Surg Endosc
. 2015 Oct;
30(7):2879-85.
PMID: 26487230
Background: Patients with gastrointestinal mucosa-associated lymphoid tissue (MALT) lymphoma require lifelong endoscopic follow-up. This study aimed to establish and evaluate confocal laser endomicroscopy (CLE) criteria for gastrointestinal MALT lymphoma. Methods:...
4.
Bojic M, Berghoff A, Troch M, Agis H, Sperr W, Widhalm G, et al.
Eur J Haematol
. 2014 Dec;
95(1):75-82.
PMID: 25546348
Primary central nervous system lymphoma (PCNSL) is a rare and malignant tumour type. Established treatment approaches include high-dose methotrexate (HD-MTX)-based chemotherapy and whole-brain radiotherapy (WBRT). WBRT is associated with significant...
5.
Schlick K, Troch M, Placher-Sorko G, Faber V, Neureiter D, Berghoff A, et al.
Ann Hematol
. 2014 Jul;
94(2):345-6.
PMID: 25055797
No abstract available.
6.
Wohrer S, Kiesewetter B, Fischbach J, Mullauer L, Troch M, Lukas J, et al.
Ann Hematol
. 2014 Mar;
93(8):1287-95.
PMID: 24633660
We have performed a retrospective analysis of all patients with extragastric mucosa-associated lymphoid tissue (MALT) lymphoma treated at our institution to compare the efficacy of first-line therapeutic modalities including surgery,...
7.
Melchardt T, Weiss L, Namberger K, Pretsch I, Hutter J, Rettenbacher L, et al.
Ann Hematol
. 2013 Nov;
93(7):1253-4.
PMID: 24263860
No abstract available.
8.
Troch M, Kiesewetter B, Willenbacher W, Willenbacher E, Zebisch A, Linkesch W, et al.
Haematologica
. 2012 Sep;
98(2):264-8.
PMID: 22983582
Currently, there is no standard systemic treatment for extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue. Both rituximab and cladribine have shown some activity in this disease, but...
9.
Kiesewetter B, Troch M, Dolak W, Mullauer L, Lukas J, Zielinski C, et al.
Haematologica
. 2012 Aug;
98(3):353-6.
PMID: 22899582
Mucosa associated lymphoid tissue lymphoma shares certain features with multiple myeloma. In view of this and the activity of lenalidomide in various B-cell lymphomas, we have initiated a phase II...
10.
Kiesewetter B, Troch M, Mullauer L, Raderer M
World J Gastrointest Oncol
. 2012 Mar;
4(2):26-9.
PMID: 22403739
Gastric B-cell lymphoma of the mucosa associated lymphoid tissue (MALT) lymphoma is one of the most common forms of extranodal lymphoma. In addition to infection with Helicobacter pylori (H. pylori),...